FDA product code NIY: Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis

NIY is the FDA product code for autoantibodies, anti-soluble liver antigen (sla), autoimmune hepatitis. It is a Class II device, regulated under 21 CFR 866.5660 and reviewed by the Immunology panel. FDA has cleared 3 510(k) submissions under NIY, from 2 different applicants. The average 510(k) review took 332 days (median 406).

Definition

ELISA for the detection of anti-SLA (soluble liver antigen) antibody of the IgG class. Intended to aid in the diagnosis of conditions with elevated levels of anti-SLA antibody including autoimmune hepatitis

Classification

FieldValue
Device nameAutoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis
Device classClass II
Regulation21 CFR 866.5660
Review panelIM — Immunology
Medical specialtyImmunology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every NIY clearance

Top NIY applicants

ApplicantClearancesLatest
Euroimmun US22013-04-12
Inova Diagnostics, Inc.12002-07-30

Most recent NIY clearances

510(k)ApplicantDeviceDecision dateReview days
K113439Euroimmun USEUROIMMUN EUROLINE PROFILE AUTOIMMUNE LIVER DISEASE 8AG (IGG)2013-04-12508
K112221Euroimmun USEUROIMMUN ANTI-SLA/LP ELISA(LGG)2012-09-11406
K021482Inova Diagnostics, Inc.QUANTA LITE SLA (SOLUBLE LIVER ANTIGEN) ELISA2002-07-3083

Recalls for NIY devices

FDA recall records list no recalls for product code NIY.

Frequently asked questions

What is FDA product code NIY?

NIY is the FDA product code for autoantibodies, anti-soluble liver antigen (sla), autoimmune hepatitis. It is a Class II device, regulated under 21 CFR 866.5660 and reviewed by the Immunology panel.

What device class is NIY?

Class II, regulation 21 CFR 866.5660. Typical premarket route: 510(k).

How long does a 510(k) take for product code NIY?

Across 3 cleared submissions the average was 332 days from receipt to decision (median 406).

Which companies have the most NIY clearances?

Euroimmun US (2); Inova Diagnostics, Inc. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times